주의력결핍 과잉행동장애에서 도파민 운반체 유전자의 10-Repeat Allele Homozygosity와 [¹²³I]IPT SPECT로 측정한 도파민 운반체 밀도가 Methylphenidate 치료 반응에 미치는 영향
Effect of Homozygosity for 10-Repeat Allele at Dopamine Transporter Gene and Dopamine Transporter Density Assessed with [123I]IPT SPECT on Response to Methylphenidate Treatment in Attention
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Abstract
Objectives:The symptoms of attention-deficit/hyperactivity disorder (ADHD) can be treated with methylphenidate, a potent blocker of the dopamine transporter (DAT). The homozygosity of the 10-repeat allele at dopamine transporter gene (DAT1) seems to be associated with a poor response to methylphenidate (MPH) in children with ADHD. In present study, we investigated association between DAT density using I-123N-(3-iodopropen-2-yl)-2β-carbomethoxy-3beta-(4-chlorophenyl)tropane ([123I]IPT SPECT) and the homozygosity for 10-repeat allele at DAT1, and response to MPH in children with ADHD. Methods:Eleven drug-naive children with ADHD were included in the study and treated with MPH for about 8 weeks. After the genotyping and SPECT were performed, we compared DAT density between ADHD children with and without the homozygosity for the 10-repeat allele at DAT1 and investigated correlation between the homozygosity for the 10-repeat allele and response to MPH. Results:ADHD children with 10/10 genotype (n=7) had a significantly higher DAT density in basal ganglia than the children without 10/10 genotype (n=4)(Right:z=-2.65, p=0.008;Left:z=-2.65, p=0.008). We found that while only 28.6% (2/7) of the subject with 10/10 genotype showed good response (≥50% improvement) to MPH treatment, 100% (4/4) of the subjects without 10/10 genotype showed good response to MPH treatment (χ2 test:F=5.238, df=1, p=0.022). Conclusion:Our findings support an association between homozygosity for the 10-repeat allele at DAT1 and the DAT density assessed in vivo and correlation between the homozygosity for the 10-repeat allele and poor response to MPH. (J Korean Neuropsychiatr Assoc 2004;43(2):151-158)
참고문헌 (25)
- "Critique of current diagnostic criteria for attention deificithyepractivity disorder:clinical and research implications", 11, pp.343~352 (1990)
- "Diagnostic and Statistical Manualfor Mental Disorders" (1994), American PsychiatricAssociation Press
- "파탄적 행동장애의 유병률에 대한 연구", 41, pp.141~149 (1991)
- "Correlates,associated impairmentsand patterns of service utilization of children with attention deificitdisorder:findings from the Ontario Child Health Study", 30, pp.205~217 (1989)
- "소아정신과와 소아과 외래환자의 과잉행동에관한 연구", 23, pp.51~57 (1980)
- "Adultoutcome of hyperactive boys", pp.565~576
- "Pharmacotherapy of attention-deficit hyperactivity disorder acrossthe life cycle", 35, pp.409~432 (1996)
- "distribution and association with lamininsand developmental switches", pp.879~891
- "Associationstudy of a dopamine transporter polymorphism and attentiondeficit hyperactivity disorder in UK and Turkish samples", 6, pp.425~428 (2001)
- "Association and linkage of the dopamine transportergene and attention-deficit hyperactivity disorder in children:heterogeneity owing to diagnostic subtype and severity", 63, pp.1767~1776 (1998)
- "Association of attention-deficit disorder and the dopaminetransporter gene", 56, pp.993~998 (1995)
- "Association of the dopamine transportergene(DAT1)with poor methylphenidate response", 38, pp.1474~1477 (1999)
- "Dopamine transporter gene and response to methylphenidate inattention-deficit", hyperactivity disorder, 2002, pp.12, 497~499
- "TheVNTR polymorphism of the human dopamine transporter(DAT1)gene affects gene expression", 1, pp.152~156 (2001)
- "Dopamine transporter gene,response to methylphenidate and cerebralblood flow in attention-deficit", hyperactivity disorder:a pilot study, 2003, pp.48, 87~89
- IPTSPET in children with attention deficit hyperactivity disorder, , 2003, 306~311
- IPT SPECT로측정한 기저 신경절 dopamine transporter density, , 2003, 61~68
- "Schedule for Affective Disorders and Schizophrenia for School-AgeChildren-Present and Life Time Version(K-SADS-PL)initial reliabilityand validity data", 36, pp.980~988 (1997)
- "The reliability and validity of Kiddie-Schedule for Affective Disordersand Schizophrenia - Present and Lifetime Version - Korean Version(K-SADS-PL-K)", 45, pp.81~89 (2004)
- "ADHD RatingScale-IV: Checklists, Norms, and Clinical Interpretation" (1998), Guilford Press
- "한국어판 부모,교사ADHD 평가 척도의 신뢰도와 타당도 연구", 41, pp.283~289 (2002)
- "maps to chromosome5p15", pp.3 1104~1106
- "A method for attenuation correction in ratio nuclidecomputed tomography", 25, pp.638~643 (1978)
- "Genotype influences in vivo dopamine transporter availability inhuman striatum", 22, pp.133~139 (2000)
- "Prediction of dopamine transporter binding availability bygenotype:a preliminary report", 157, pp.1700~1703 (2000)
